FdaApplication
NDA 213591
Identifiers
- fda_app_no: NDA213591
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICAL CORP |
| application_type | NDA |
| approval_date | 2020-05-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TABRECTA | CAPMATINIB HYDROCHLORIDE | EQ 200MG BASE | TABLET;ORAL |
| TABRECTA | CAPMATINIB HYDROCHLORIDE | EQ 150MG BASE | TABLET;ORAL |
2 products